iScience · 2022 · 12 citations · 67 references
MedicineCancer BiologyOncologyCancer PharmacologyMolecular OncologyTumor MicroenvironmentCancer ImmunotherapyExtracellular Vesicle SignalingGlioblastomaImmunotherapy For Brain TumorsTumor Microenvironment ModulationVesicle TraffickingExtracellular Vesicle ReleaseGlioblastoma Cell SignalingGlioblastoma Drug TherapyGlioblastoma ImmunotherapyGlioblastoma Targeted TherapyGlioblastoma Therapeutic ResistanceGlioblastoma Tumor BiologyGlioblastoma Tumor Microenvironment
, pharmacological inhibition of MLKL reduces the tumor burden and the level of plasmatic EVs. This work highlights the necroptosis-independent role of MLKL in vesicle release and suggests that interfering with EVs is a promising therapeutic option to sensitize glioblastoma cells.
67
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Clotilde Théry, Kenneth W. Witwer, Elena Aïkawa et al. · Journal of Extracellular Vesicles · 2018 · 11.2K citations · Full text
Roel G.W. Verhaak, Katherine A. Hoadley, Elizabeth Purdom et al. · Cancer Cell · 2010 · 7.7K citations · Full text
Identification of human brain tumour initiating cells
Sheila K. Singh, Cynthia Hawkins, Ian D. Clarke et al. · Nature · 2004 · 7.4K citations
Medicine, Cancer Biology, Oncology +11
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao, Qiulian Wu, Roger E. McLendon et al. · Nature · 2006 · 6.4K citations
Medicine, Cancer Biology, Oncology +16